FDA Expands Approval of Evinacumab-dgnb (Evkeeza) for Homozygous Familial Hypercholesterolemia in Children as Young as One 3 min read Pharma News FDA Expands Approval of Evinacumab-dgnb (Evkeeza) for Homozygous Familial Hypercholesterolemia in Children as Young as One Pharm'Up The US Food and Drug Administration (FDA) has granted an expanded indication for evinacumab-dgnb (Evkeeza), a fully... Read More Read more about FDA Expands Approval of Evinacumab-dgnb (Evkeeza) for Homozygous Familial Hypercholesterolemia in Children as Young as One
Pharm'Up 
